46 results in Exploration of Digestive Diseases
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
Anastasia Rays ... Аlexey Tryakin
Published: March 27, 2025 Explor Dig Dis. 2025;4:100568
This article belongs to the special issue Immunotherapy for Cancer of Digestive System
Open Access
Letter to the Editor
Helicobacter pylori infection in the pathophysiology of metabolic dysfunction-associated steatotic liver disease and its complications
Jannis Kountouras ... Maria Tzitiridou-Chatzopoulou
Published: March 20, 2025 Explor Dig Dis. 2025;4:100567
Open Access
Review
Mitochondrial dysfunction in PBMC: a potential sensor for metabolic dysfunction-associated steatotic liver disease and therapeutic insight for NAD+-increasing strategies
Julia Niño-Narvión ... Josep Julve
Published: February 26, 2025 Explor Dig Dis. 2025;4:100566
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
Hepatitis B virus induced cirrhosis and hepatocarcinoma: pathogenesis and therapeutics
Juntian Yao ... Youhua Xie
Published: February 21, 2025 Explor Dig Dis. 2025;4:100565
This article belongs to the special issue Viral Hepatitis
Open Access
Review
Current efficacy of immune checkpoint inhibitors in microsatellite unstable colorectal cancer and potential biomarkers
Mariam Rojas ... Joan Maurel
Published: February 18, 2025 Explor Dig Dis. 2025;4:100564
This article belongs to the special issue Immunotherapy for Cancer of Digestive System
Open Access
Review
Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?
Zahid Hussain
Published: January 15, 2025 Explor Dig Dis. 2025;4:100563
PreviousJournal Information